Botulinum Toxin Type A: Adverse Events and Management

被引:3
|
作者
Cavallini, Maurizio [1 ]
Papagni, Marco [2 ]
Lazzari, Riccardo [2 ]
Santorelli, Adriano [3 ]
机构
[1] Ctr Diagnost Italiano Hosp, Operat Unit Dermatol & Dermato Surg, Milan, Italy
[2] Italian Sci Soc Aesthet Med, Milan, Italy
[3] Acad Aesthet Sci, Naples, Italy
关键词
botulinum toxin; depressor anguli oris; adverse events; safety; Onabotulinum toxin-A; DOUBLE-BLIND; INJECTION; CONSENSUS;
D O I
10.1055/s-0041-1741531
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aesthetic medicine is witnessing an increasing exploitation of all the procedures. The demand has never been higher than it is today. The number of practitioners is also increasing year by year. Consequently complications and other kinds of related troubles and procedures are also rising. Never like today is fundamental, in case of troubles, how to properly manage with the most frequent issues. In aesthetic medicine field, botulinum toxin procedures are the safest. Lot of patients are worried about botulinum toxin despite the available scientific literature. Rare short-term complications are observed. In the most of cases, nothing severe occurs if the international recommendations and the most recent guidelines are closely followed, the majority of them are injection related. This study is a review of rare or common problems that can occur and how to manage or solve the situations.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 50 条
  • [21] Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection
    LeWitt, PA
    Trosch, RM
    MOVEMENT DISORDERS, 1997, 12 (06) : 1064 - 1067
  • [22] Botulinum toxin type A injections:: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases
    Coté, TR
    Mohan, AK
    Polder, JA
    Walton, MK
    Braun, MM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (03) : 407 - 415
  • [23] Re: Predictors for Adverse Events Following Intravesical Botulinum Toxin Injections in Men
    Elliott, Sean P.
    JOURNAL OF UROLOGY, 2024, 211 (02): : 333 - 334
  • [25] Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy
    Naidu, Krishant
    Smith, Katherine
    Sheedy, Mary
    Adair, Brooke
    Yu, Xavier
    Graham, H. Kerr
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2010, 52 (02): : 139 - 144
  • [26] Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections
    Swinney, Caitlyn M.
    Bau, Karen
    Burton, Karen L. Oakley
    O'Flaherty, Stephen J.
    Bear, Natasha L.
    Paget, Simon P.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2018, 60 (05): : 498 - 504
  • [27] Systemic Adverse Events Following Botulinum Toxin A Therapy in Children With Cerebral Palsy
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2011, 185 (06): : 2347 - 2347
  • [28] Botulinum toxin type A in the management of masseter muscle hypertrophy
    Castro, WH
    Gomez, RS
    Oliveira, JD
    Moura, MDG
    Gomez, RS
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2005, 63 (01) : 20 - 24
  • [29] The Effectiveness of Botulinum Toxin Type A Injections in the Management of Sialorrhea
    Surmelioglu, Ozgur
    Dagkiran, Muhammed
    Tuncer, Ulku
    Ozdemir, Suleyman
    Tarkan, Ozgur
    Cetik, Fikret
    Kiroglu, Mete
    TURKISH ARCHIVES OF OTORHINOLARYNGOLOGY, 2018, 56 (02) : 111 - 113
  • [30] Botulinum toxin type A in the management of a neuropathic foot ulcer
    Alsharqi, A.
    Curley, R.
    Winhoven, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2011, 36 (08) : 915 - 916